PUBLISHER: TechSci Research | PRODUCT CODE: 1968514
PUBLISHER: TechSci Research | PRODUCT CODE: 1968514
Vasectomy Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type, By Patient, By End-User, By Region & Competition, 2021-2031F
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The Global Vasectomy Market is projected to expand from USD 23.11 Billion in 2025 to USD 36.21 Billion by 2031, registering a CAGR of 7.77%. Vasectomy is defined as a surgical method for male sterilization that ensures permanent contraception by blocking the vas deferens to prevent sperm from entering the seminal fluid. Market growth is largely driven by the procedure's cost-effectiveness compared to female sterilization and the rising adoption of minimally invasive no-scalpel techniques, which offer reduced recovery times. This increasing acceptance is reflected in operational data; according to NHS England Digital, the 2024 fiscal year saw Sexual and Reproductive Health services in England perform 22,775 vasectomy procedures, indicating a strong uptake.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 23.11 Billion |
| Market Size 2031 | USD 36.21 Billion |
| CAGR 2026-2031 | 7.77% |
| Fastest Growing Segment | Conventional |
| Largest Market | North America |
Despite these favorable conditions, market growth is hampered by enduring cultural stigmas and psychological concerns related to masculinity and sexual potency. The permanent nature of the surgery instills hesitation in potential patients who fear future regret or physiological changes. Consequently, a lack of effective educational initiatives to debunk these myths restricts deeper market penetration, especially in conservative regions where knowledge regarding the safety and specific nature of the procedure remains inadequate.
Market Driver
A primary catalyst for market growth is the increasing involvement of men in family planning, which marks a shift from contraception being viewed solely as a female responsibility. This trend is defined by a significant demographic expansion, with younger men increasingly choosing sterilization due to the evolving reproductive rights landscape and a desire for shared accountability. Data from the American Urological Association's 2024 Annual Meeting highlights this shift, reporting that following legal changes in the United States, the percentage of vasectomy patients under 30 rose to 9.8%. This broadening demographic reduces the market's historical dependence on older men who have already completed their families.
Concurrently, demand for permanent contraception is being boosted by government programs and NGO efforts aimed at improving procedure accessibility. These organizations play a vital role in overcoming cost barriers and normalizing the surgery through subsidies and education, effectively turning interest into actual procedures. The magnitude of this demand is evident in the NHS England Digital report from September 2024, which recorded a dramatic 113% year-on-year increase in vasectomy procedures. Additionally, the Planned Parenthood Federation of America served 5,388 vasectomy clients in 2024, underscoring the essential role of accessible providers in meeting the rising global demand for male sterilization.
Market Challenge
Market growth is significantly obstructed by persistent cultural stigmas and psychological barriers concerning masculinity and sexual potency. These deep-rooted misconceptions, combined with the finality of the procedure, generate considerable hesitation among men who fear regret or physiological alterations. A common but unfounded belief equates fertility with virility, leading many to view vasectomy as a form of castration or a cause of diminished sexual performance. This psychological resistance acts as a major restraint, particularly in conservative societies where male dominance in reproductive decision-making is culturally ingrained.
Although the procedure has a high clinical success rate, these fears continue to limit its widespread adoption. There is a marked discrepancy between public perception and medical reality, as highlighted by 2024 data from the British Association of Urological Surgeons, which reported a late procedural failure rate of only 1 in 2,000 and chronic pain affecting just 1-2% of patients. However, the prevalence of myths regarding failure and side effects obscures these favorable statistics, causing global vasectomy uptake to lag significantly behind that of female sterilization methods.
Market Trends
Biotechnology companies are actively pursuing the commercialization of non-hormonal, polymer-based occlusives to create a new market segment for reversible male sterilization. This innovation tackles the psychological barrier of permanence by using injectable hydrogels that block sperm flow without severing the vas deferens, providing a flexible alternative to traditional ligation. Progress in this area is rapid; according to Femtech Insider in April 2025, the 'ADAM' hydrogel system achieved a key milestone at the American Urological Association meeting, where early trial results showed two participants maintained safety and azoospermia at the 24-month mark.
Simultaneously, digital health advocacy is driving a cultural shift that is dismantling historical stigmas and rebranding vasectomy as a responsible lifestyle choice. Social media influencers and patient testimonials are normalizing the procedure, thereby accelerating demand among groups previously hesitant to seek reproductive health services. This destigmatization is fueling measurable growth; according to Population Connection in March 2025, increased public interest has compounded clinical demand, with a study noting that young men are utilizing vasectomy services at a rate 95% higher than previous baselines in response to the changing reproductive landscape.
Key Market Players
- Pfizer Inc
- Bristol Myers Squibb SA
- Teva Pharmaceuticals USA Inc
- Upsher-Smith Laboratories Inc
- SMITHFIELD BIOSCIENCE
- Opocrin SPA
- Bioiberica SA
- GSK PLC
- Johnson & Johnson Consumer Inc
- Fresenius SE & Co KGaA
Report Scope
In this report, the Global Vasectomy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Vasectomy Market, By Type
- Conventional
- Minimally Invasive
- No-Scalpel
Vasectomy Market, By Patient
- Animal
- Human
Vasectomy Market, By End-User
- Hospitals & Clinics
- Ambulatory Care Centers
- Others
Vasectomy Market, By Region
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Vasectomy Market.
Available Customizations:
Global Vasectomy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Vasectomy Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Type (Conventional, Minimally Invasive, No-Scalpel)
- 5.2.2. By Patient (Animal, Human)
- 5.2.3. By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2025)
- 5.3. Market Map
6. North America Vasectomy Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Patient
- 6.2.3. By End-User
- 6.2.4. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Vasectomy Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Type
- 6.3.1.2.2. By Patient
- 6.3.1.2.3. By End-User
- 6.3.1.1. Market Size & Forecast
- 6.3.2. Canada Vasectomy Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Type
- 6.3.2.2.2. By Patient
- 6.3.2.2.3. By End-User
- 6.3.2.1. Market Size & Forecast
- 6.3.3. Mexico Vasectomy Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Type
- 6.3.3.2.2. By Patient
- 6.3.3.2.3. By End-User
- 6.3.3.1. Market Size & Forecast
- 6.3.1. United States Vasectomy Market Outlook
7. Europe Vasectomy Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Patient
- 7.2.3. By End-User
- 7.2.4. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. Germany Vasectomy Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Type
- 7.3.1.2.2. By Patient
- 7.3.1.2.3. By End-User
- 7.3.1.1. Market Size & Forecast
- 7.3.2. France Vasectomy Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Type
- 7.3.2.2.2. By Patient
- 7.3.2.2.3. By End-User
- 7.3.2.1. Market Size & Forecast
- 7.3.3. United Kingdom Vasectomy Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Type
- 7.3.3.2.2. By Patient
- 7.3.3.2.3. By End-User
- 7.3.3.1. Market Size & Forecast
- 7.3.4. Italy Vasectomy Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Type
- 7.3.4.2.2. By Patient
- 7.3.4.2.3. By End-User
- 7.3.4.1. Market Size & Forecast
- 7.3.5. Spain Vasectomy Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Type
- 7.3.5.2.2. By Patient
- 7.3.5.2.3. By End-User
- 7.3.5.1. Market Size & Forecast
- 7.3.1. Germany Vasectomy Market Outlook
8. Asia Pacific Vasectomy Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Patient
- 8.2.3. By End-User
- 8.2.4. By Country
- 8.3. Asia Pacific: Country Analysis
- 8.3.1. China Vasectomy Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Type
- 8.3.1.2.2. By Patient
- 8.3.1.2.3. By End-User
- 8.3.1.1. Market Size & Forecast
- 8.3.2. India Vasectomy Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Type
- 8.3.2.2.2. By Patient
- 8.3.2.2.3. By End-User
- 8.3.2.1. Market Size & Forecast
- 8.3.3. Japan Vasectomy Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Type
- 8.3.3.2.2. By Patient
- 8.3.3.2.3. By End-User
- 8.3.3.1. Market Size & Forecast
- 8.3.4. South Korea Vasectomy Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Type
- 8.3.4.2.2. By Patient
- 8.3.4.2.3. By End-User
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Australia Vasectomy Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Type
- 8.3.5.2.2. By Patient
- 8.3.5.2.3. By End-User
- 8.3.5.1. Market Size & Forecast
- 8.3.1. China Vasectomy Market Outlook
9. Middle East & Africa Vasectomy Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Patient
- 9.2.3. By End-User
- 9.2.4. By Country
- 9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Vasectomy Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Type
- 9.3.1.2.2. By Patient
- 9.3.1.2.3. By End-User
- 9.3.1.1. Market Size & Forecast
- 9.3.2. UAE Vasectomy Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Type
- 9.3.2.2.2. By Patient
- 9.3.2.2.3. By End-User
- 9.3.2.1. Market Size & Forecast
- 9.3.3. South Africa Vasectomy Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Type
- 9.3.3.2.2. By Patient
- 9.3.3.2.3. By End-User
- 9.3.3.1. Market Size & Forecast
- 9.3.1. Saudi Arabia Vasectomy Market Outlook
10. South America Vasectomy Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Patient
- 10.2.3. By End-User
- 10.2.4. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Vasectomy Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Type
- 10.3.1.2.2. By Patient
- 10.3.1.2.3. By End-User
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Colombia Vasectomy Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Type
- 10.3.2.2.2. By Patient
- 10.3.2.2.3. By End-User
- 10.3.2.1. Market Size & Forecast
- 10.3.3. Argentina Vasectomy Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Type
- 10.3.3.2.2. By Patient
- 10.3.3.2.3. By End-User
- 10.3.3.1. Market Size & Forecast
- 10.3.1. Brazil Vasectomy Market Outlook
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Merger & Acquisition (If Any)
- 12.2. Product Launches (If Any)
- 12.3. Recent Developments
13. Global Vasectomy Market: SWOT Analysis
14. Porter's Five Forces Analysis
- 14.1. Competition in the Industry
- 14.2. Potential of New Entrants
- 14.3. Power of Suppliers
- 14.4. Power of Customers
- 14.5. Threat of Substitute Products
15. Competitive Landscape
- 15.1. Pfizer Inc
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
- 15.2. Bristol Myers Squibb SA
- 15.3. Teva Pharmaceuticals USA Inc
- 15.4. Upsher-Smith Laboratories Inc
- 15.5. SMITHFIELD BIOSCIENCE
- 15.6. Opocrin SPA
- 15.7. Bioiberica SA
- 15.8. GSK PLC
- 15.9. Johnson & Johnson Consumer Inc
- 15.10. Fresenius SE & Co KGaA
16. Strategic Recommendations
17. About Us & Disclaimer
